Client’s Testimonial:
“Thank you for all your excellent work and for sharing the great news.”
On February 4th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a PhD Student in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: PhD Student
Country of Origin: Iran
State of Residence at the Time of Filing: North Carolina
Approval Notice Date: February 4th, 2025
Processing Time: 5 months, 16 days
Case Summary:
When the Client first set out on the path of biomedical engineering, his vision was clear: to harness the power of stem cell technology and material science to create solutions for some of the most urgent medical challenges of our time. With an M.S. in medical biotechnology, the Client has focused his career on engineering accurate multicellular systems and novel therapies designed to address the shortage of human organs for transplant, provide better models for drug discovery, and design advanced delivery systems to treat diseases such as cardiovascular disease, chronic kidney disease, and cancer.
This endeavor is not only scientifically ambitious but also of profound national importance. By creating accurate biological models and developing innovative therapeutic platforms, the Client’s research holds the potential to transform healthcare delivery in the United States, saving lives while reducing costs and improving patient outcomes.
Over the course of his career, the Client has authored 6 peer-reviewed journal articles, including 1 first-authored and 2 co-first-authored papers, with an additional article already accepted for publication. His work has been cited 719 times according to Google Scholar, a clear measure of its influence and utility across the global biomedical research community. Beyond publications, he has also been entrusted with at least 3 peer review assignments, a mark of professional recognition that underscores his authority in evaluating cutting-edge science.
Importantly, the strength of his case was bolstered by 2 recommendation letters from established experts in the field, each attesting to the originality, significance, and translational potential of his work.
“[Client’s] skillset is irreplaceable, given its immense benefits to stem cell research, healthcare, and medical advancement. It is imperative that he be allowed to carry out his research uninterrupted so that the United States is able to benefit fully from its value.”
Despite the rigorous scrutiny of the NIW process, USCIS recognized that the Client’s proposed endeavor carries substantial merit and national importance, and that he is well-positioned to advance this critical work.
The approval of his I-140 NIW petition affirms not only the Client’s track record of impactful contributions but also his potential to continue driving innovation in regenerative medicine, therapeutic development, and organ transplantation research. This milestone also reflects our firm’s commitment to guiding talented researchers through the complexities of the NIW process and ensuring their expertise is recognized at the national level.
North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).
Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend
With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.
We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours
With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.
Vast Majority of Clients Came to Us Because of Referrals
For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.
Approval Notices: https://www.wegreened.com/eb1_niw_approvals
Success Stories: https://www.wegreened.com/blog/
Website: www.wegreened.com
Free evaluation: https://www.wegreened.com/Free-Evaluation
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to:
To Learn More About Your Options CLICK HERE
Copyright © North America Immigration Law Group – WeGreened.com, All Rights Reserved.